Letters to the Editor

High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation in context with the CD34+/CD38- population

Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy,Leipzig University Hospital,Germany
Vol. 105 No. 10 (2020): October, 2020 https://doi.org/10.3324/haematol.2019.229260